TotalMarketCap

Amylyx Pharmaceuticals

AMLXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.481 B

$27.75 -5.61%

Close of 6 Nov 2026

As of 6 Nov 2026, Amylyx Pharmaceuticals (AMLX) has a market capitalization of $3.48B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$144.7M

Loss-making

Shares outstanding

128,562,904

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #65Tango TherapeuticsTNGX$3.52B
  2. #66Disc MedicineIRON$3.49B
  3. #67Amylyx PharmaceuticalsAMLX$3.48B
  4. #68Arcutis BiotherapeuticsARQT$3.42B
  5. #69Parabilis MedicinesPBLS$3.41B

What if Amylyx Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$225,069.83

Per share 8,111× higher

Bitcoin $1.53T

$12,178.14

Per share 439× higher

Apple $5.02T

$39,979.68

Per share 1,441× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Amylyx Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.